Literature DB >> 26072958

Hyperactivity and impaired attention in Gamma aminobutyric acid transporter subtype 1 gene knockout mice.

Long Chen1, Xiaobo Yang1, Xiaoyong Zhou1, Cuicui Wang1, Xue Gong1, Biqin Chen2, Yinghui Chen1.   

Abstract

OBJECTIVES: Attention-deficit hyperactivity disorder (ADHD) is a common neurobehavioural disorder. It is conceivable that Gamma aminobutyric acid (GABA) neurotransmission is implicated in the pathophysiology of ADHD. This study investigated the effect of GABA transporter 1 (GAT-1) on the anxiety-like behaviours and cognitive function in knockout mice.
METHODS: In all, 20 adult male mice were divided into two groups: wild-type (WT) group and GAT-1-/- group. The open field test, elevated O-maze (EZM) and Morris water maze were used to evaluate behavioural traits relevant to ADHD.
RESULTS: Compared with WT mice, the GAT-1-/- mice travelled longer and displayed an enhanced kinematic velocity with the significant reduction of rest time in the open field test (p<0.05). The EZM showed that GAT-1-/- mice displayed a significant increase in total entries into the open sectors and the closed sectors compared with the WT mice. The WT mice showed shorter latencies after the training session (p<0.01), whereas the GAT-1-/- mice made no difference during probe test, the GAT-1-/- mice spent less time in the target quadrant (p<0.01).
CONCLUSION: Our results demonstrated that GAT-1-/- mice have phenotypes of hyperactivity, impaired sustained attention and learning deficiency, and the performance of GAT-1-/- mice is similar to ADHD symptoms. So, the study of the GAT-1-/- mice may provide new insights into the mechanisms and the discovery of novel therapeutics for the treatment of ADHD.

Entities:  

Keywords:  GABA transporters 1; Gamma aminobutyric acid; attention-deficit hyperactivity disorder

Mesh:

Substances:

Year:  2015        PMID: 26072958     DOI: 10.1017/neu.2015.37

Source DB:  PubMed          Journal:  Acta Neuropsychiatr        ISSN: 0924-2708            Impact factor:   3.403


  12 in total

Review 1.  Neuroinflammation as a risk factor for attention deficit hyperactivity disorder.

Authors:  Geoffrey A Dunn; Joel T Nigg; Elinor L Sullivan
Journal:  Pharmacol Biochem Behav       Date:  2019-05-16       Impact factor: 3.533

2.  Defining the phenotypic spectrum of SLC6A1 mutations.

Authors:  Katrine M Johannesen; Elena Gardella; Tarja Linnankivi; Carolina Courage; Anne de Saint Martin; Anna-Elina Lehesjoki; Cyril Mignot; Alexandra Afenjar; Gaetan Lesca; Marie-Thérèse Abi-Warde; Jamel Chelly; Amélie Piton; J Lawrence Merritt; Lance H Rodan; Wen-Hann Tan; Lynne M Bird; Mark Nespeca; Joseph G Gleeson; Yongjin Yoo; Murim Choi; Jong-Hee Chae; Desiree Czapansky-Beilman; Sara Chadwick Reichert; Manuela Pendziwiat; Judith S Verhoeven; Helenius J Schelhaas; Orrin Devinsky; Jakob Christensen; Nicola Specchio; Marina Trivisano; Yvonne G Weber; Caroline Nava; Boris Keren; Diane Doummar; Elise Schaefer; Sarah Hopkins; Holly Dubbs; Jessica E Shaw; Laura Pisani; Candace T Myers; Sha Tang; Shan Tang; Deb K Pal; John J Millichap; Gemma L Carvill; Kathrine L Helbig; Oriano Mecarelli; Pasquale Striano; Ingo Helbig; Guido Rubboli; Heather C Mefford; Rikke S Møller
Journal:  Epilepsia       Date:  2018-01-08       Impact factor: 5.864

Review 3.  Exploring the Validity of Proposed Transgenic Animal Models of Attention-Deficit Hyperactivity Disorder (ADHD).

Authors:  June Bryan de la Peña; Irene Joy Dela Peña; Raly James Custodio; Chrislean Jun Botanas; Hee Jin Kim; Jae Hoon Cheong
Journal:  Mol Neurobiol       Date:  2017-05-22       Impact factor: 5.590

4.  Protective Effects of Thymoquinone Against Convulsant Activity Induced by Lithium-Pilocarpine in a model of Status Epilepticus.

Authors:  Yiye Shao; Yonghao Feng; Yangmei Xie; Qiong Luo; Long Chen; Bing Li; Yinghui Chen
Journal:  Neurochem Res       Date:  2016-10-18       Impact factor: 3.996

Review 5.  Functional and Biochemical Consequences of Disease Variants in Neurotransmitter Transporters: A Special Emphasis on Folding and Trafficking Deficits.

Authors:  Shreyas Bhat; Ali El-Kasaby; Michael Freissmuth; Sonja Sucic
Journal:  Pharmacol Ther       Date:  2020-12-10       Impact factor: 12.310

6.  Thymoquinone Attenuates Brain Injury via an Anti-oxidative Pathway in a Status Epilepticus Rat Model.

Authors:  Yi-Ye Shao; Bing Li; Yong-Mei Huang; Qiong Luo; Yang-Mei Xie; Ying-Hui Chen
Journal:  Transl Neurosci       Date:  2017-03-25       Impact factor: 1.757

7.  Prioritized High-Confidence Risk Genes for Intellectual Disability Reveal Molecular Convergence During Brain Development.

Authors:  Zhenwei Liu; Na Zhang; Yu Zhang; Yaoqiang Du; Tao Zhang; Zhongshan Li; Jinyu Wu; Xiaobing Wang
Journal:  Front Genet       Date:  2018-09-18       Impact factor: 4.599

Review 8.  Neuron-Glia Interactions in Neurodevelopmental Disorders.

Authors:  Yoo Sung Kim; Juwon Choi; Bo-Eun Yoon
Journal:  Cells       Date:  2020-09-27       Impact factor: 6.600

Review 9.  Reconstitution of GABA, Glycine and Glutamate Transporters.

Authors:  Niels Christian Danbolt; Beatriz López-Corcuera; Yun Zhou
Journal:  Neurochem Res       Date:  2021-04-27       Impact factor: 3.996

10.  Vascular amyloid accumulation alters the gabaergic synapse and induces hyperactivity in a model of cerebral amyloid angiopathy.

Authors:  Pablo Cisternas; Xavier Taylor; Abigail Perkins; Orlando Maldonado; Elysabeth Allman; Ricardo Cordova; Yamil Marambio; Braulio Munoz; Taylor Pennington; Shunian Xiang; Jie Zhang; Ruben Vidal; Brady Atwood; Cristian A Lasagna-Reeves
Journal:  Aging Cell       Date:  2020-09-10       Impact factor: 11.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.